Lenvatinib 4mg capsules
NHS hospitals in England used £22,905,080 of indicative cost of Lenvatinib 4mg capsules in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 24.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenvatinib 4mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenvatinib 4mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Barts Health Nhs Trust | £6,374,005 |
| The Christie Nhs Foundation Trust | £1,057,009 |
| The Royal Marsden Nhs Foundation Trust | £814,923 |
| Cambridge Univ Hosp Nhs Foundation Trust | £732,678 |
| Imperial College Healthcare Nhs Trust | £647,848 |
| Leeds Teaching Hpls Nhs Trust | £638,124 |
| Univ Hpl B/Ham Nhs Foundation Trust | £617,335 |
| The Clatterbridge Cancer Centre Nhs Ft | £602,965 |
| East And North Hertfordshire Nhs Trust | £566,801 |
| Royal Free London Nhs Foundation Trust | £558,849 |
The primary-care picture
Lenvatinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenvatinib medicine page.